GGrantIndex
Sort

50,496 grants matching lung cancer

E3 ubiquitin ligase RNF145 in airway smooth muscle functions and in asthma

$472,898
Pawan Sharma · Thomas Jefferson University · R01 · FY2023 · HL

E3 ubiquitin ligase RNF145 in airway smooth muscle functions and in asthma

$472,898
Pawan Sharma · Thomas Jefferson University · R01 · FY2022 · HL

Project 4: Therapeutic Targeting of Replication Stress Vulnerabilities in Small Cell Lung Cancer

$472,890
Lauren Averett Byers · Ut Southwestern Medical Center · P50 · FY2020 · CA

The Epidemiology of Molecular Alterations in Mesothelioma

$472,838
Karl T Kelsey · Brown University · R01 · FY2011 · CA

Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities

$472,799
Jlenia Guarnerio · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Prospective validation of a multi-marker prostate cancer prediction model

$472,760
Hans Gã–sta Lilja · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA

Integrated analyses of cancers harboring STK11 vs. TSC1/2 vs. PTEN Loss

$472,743
David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2016 · CA

Elucidating the Role of the Tumor Suppressor KEAP1 in Antitumor Immunity

$472,730
Antonio Marzio · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA

Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy

$472,671
Roman Perez-Soler · Albert Einstein College Of Medicine · R01 · FY2013 · CA

New mouse model of cisplatin-induced AKI and development of prevention therapy

$472,634
Jianjun Zhao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · CA

RADIOPHARMACY AND ASSAYS

$472,615
David Morris Colcher · Beckman Research Institute/City Of Hope · P01 · FY2007 · CA

Leucine Type Amino Acid Transport In Gliomas

$472,586
Mark Myron Goodman · Emory University · R01 · FY2009 · CA

Improving pathologic nodal staging of resected lung cancer

$472,577
Raymond U Osarogiagbon · Baptist Memorial Hospital - Tipton · R01 · FY2022 · CA

Obesity, Metabolism and Breast Cancer Metastasis

$472,530
Dorothy Teegarden · Purdue University · R01 · FY2019 · CA

Interpretable graphical models for large multi-modal COPD data (R01HL159805)

$472,526
Panagiotis V Benos · University Of Florida · R01 · FY2023 · HL

Deriving Bone Density from Thoracic CT Scans, STTR Phase II

$472,431
Mike Allen · Bdi, Inc. · R42 · FY2018 · AR

Methods for Etiologic Studies of Diet and Cancer

$472,346
Rashmi Sinha · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA

Epigenetic control of skin homeostasis by the ULK3 nuclear kinase

$472,342
Gian Paolo Dotto · Massachusetts General Hospital · R01 · FY2022 · AR

Community Outreach & Engagement

$472,325
Jason A Mendoza · Fred Hutchinson Cancer Research Center · P30 · FY2020 · CA

Navajo Uranium Assessment and Kidney Health Project

$472,309
Johnnye L Lewis · University Of New Mexico · R01 · FY2006 · ES

A no-gold-standard framework to objectively evaluate quantitative imaging methods with patient data

$472,263
Abhinav K Jha · Washington University · R01 · FY2023 · EB

Cancer Immunotherapy Clinical Trials

$472,182
Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Urokinase-type plasminogen activator (uPA) in pathogenesis of lymphangioleiomyomatosis (LAM)

$472,155
Victoria Stepanova · University Of Pennsylvania · R01 · FY2019 · HL

Project 3: From Networks and Structures to Hierarchical Whole­ Cell Models of Cancer

$472,142
Trey Ideker · University Of California, San Francisco · U54 · FY2024 · CA

The function of the PRMT5 methylosome in MTAP deleted cancers

$472,119
William R Sellers · Broad Institute, Inc. · R01 · FY2025 · CA